Pharma Mar, S.A. (BME: PHM)
Spain
· Delayed Price · Currency is EUR 78.50
-2.25 (-2.79%)
Dec 20, 2024, 5:35 PM CET
Pharma Mar Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 167 | 158.15 | 196.34 | 229.83 | 269.96 | 85.82 | Upgrade
|
| Revenue Growth (YoY) | -0.86% | -19.45% | -14.57% | -14.87% | 214.57% | -21.10% | Upgrade
|
| Cost of Revenue | 9.32 | 9.61 | 13.64 | 16.44 | 13.72 | 5.23 | Upgrade
|
| Gross Profit | 157.68 | 148.54 | 182.7 | 213.39 | 256.24 | 80.59 | Upgrade
|
| Selling, General & Admin | 45.36 | 41.81 | 43.24 | 39.74 | 35.77 | 37.82 | Upgrade
|
| Research & Development | 104.96 | 99.3 | 83.45 | 72.17 | 53.79 | 50.64 | Upgrade
|
| Other Operating Expenses | 10.9 | 11.26 | 13.94 | 9.04 | 9.77 | 9.61 | Upgrade
|
| Operating Expenses | 161.23 | 152.37 | 140.63 | 120.95 | 99.6 | 98.07 | Upgrade
|
| Operating Income | -3.54 | -3.83 | 42.07 | 92.45 | 156.64 | -17.48 | Upgrade
|
| Interest Expense | -2.42 | -2.42 | -2.38 | -3.37 | -3.12 | -3.89 | Upgrade
|
| Interest & Investment Income | 3.41 | 4.1 | 0.88 | 0.37 | 0.34 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.68 | -1.68 | 3.11 | 5.67 | -7.55 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | -4.23 | -3.82 | 43.68 | 95.12 | 146.31 | -21.39 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.2 | 0.2 | -1.89 | 0.01 | -0.7 | -0.27 | Upgrade
|
| Other Unusual Items | - | - | 2 | - | - | - | Upgrade
|
| Pretax Income | -4.03 | -3.62 | 43.79 | 95.13 | 145.61 | -21.65 | Upgrade
|
| Income Tax Expense | -4.66 | -4.76 | -5.57 | 2.27 | 8.34 | -12.47 | Upgrade
|
| Earnings From Continuing Operations | 0.62 | 1.14 | 49.36 | 92.86 | 137.26 | -9.18 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -2.22 | Upgrade
|
| Net Income to Company | 0.62 | 1.14 | 49.36 | 92.86 | 137.26 | -11.4 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | - | 0.02 | Upgrade
|
| Net Income | 0.62 | 1.14 | 49.36 | 92.86 | 137.26 | -11.38 | Upgrade
|
| Net Income to Common | 0.62 | 1.14 | 49.36 | 92.86 | 137.26 | -11.38 | Upgrade
|
| Net Income Growth | -95.54% | -97.70% | -46.85% | -32.35% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 18 | 18 | 18 | 18 | 18 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 18 | 18 | 18 | 18 | 18 | Upgrade
|
| Shares Change (YoY) | - | -0.81% | -0.12% | -1.31% | -0.77% | 0.29% | Upgrade
|
| EPS (Basic) | 0.04 | 0.06 | 2.73 | 5.14 | 7.50 | -0.62 | Upgrade
|
| EPS (Diluted) | 0.03 | 0.06 | 2.73 | 5.13 | 7.49 | -0.62 | Upgrade
|
| EPS Growth | - | -97.80% | -46.78% | -31.51% | - | - | Upgrade
|
| Free Cash Flow | -17.67 | -29.4 | 29.47 | 17.87 | 275.94 | -28.17 | Upgrade
|
| Free Cash Flow Per Share | -1.01 | -1.64 | 1.63 | 0.99 | 15.06 | -1.53 | Upgrade
|
| Dividend Per Share | 0.650 | 0.650 | 0.650 | 0.650 | 0.600 | 0.480 | Upgrade
|
| Dividend Growth | 0% | 0% | 0% | 8.33% | 25.00% | - | Upgrade
|
| Gross Margin | 94.42% | 93.92% | 93.05% | 92.85% | 94.92% | 93.91% | Upgrade
|
| Operating Margin | -2.12% | -2.42% | 21.43% | 40.22% | 58.02% | -20.36% | Upgrade
|
| Profit Margin | 0.37% | 0.72% | 25.14% | 40.40% | 50.85% | -13.26% | Upgrade
|
| Free Cash Flow Margin | -10.58% | -18.59% | 15.01% | 7.78% | 102.21% | -32.83% | Upgrade
|
| EBITDA | -0.48 | -1.15 | 44.88 | 94.99 | 159.09 | -15.15 | Upgrade
|
| EBITDA Margin | -0.29% | -0.72% | 22.86% | 41.33% | 58.93% | -17.65% | Upgrade
|
| D&A For EBITDA | 3.07 | 2.68 | 2.81 | 2.54 | 2.45 | 2.33 | Upgrade
|
| EBIT | -3.54 | -3.83 | 42.07 | 92.45 | 156.64 | -17.48 | Upgrade
|
| EBIT Margin | -2.12% | -2.42% | 21.43% | 40.22% | 58.02% | -20.36% | Upgrade
|
| Effective Tax Rate | - | - | - | 2.39% | 5.73% | - | Upgrade
|
| Revenue as Reported | 167 | 158.15 | 196.34 | 229.83 | 269.96 | 85.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.